54th Annual Meeting of the Society For Leukocyte Biology
白细胞生物学学会第 54 届年会
基本信息
- 批准号:10318756
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acute DiseaseAgingAirway DiseaseAmericanAutoimmunityAwarenessBasic ScienceBiologyCOVID-19Chronic DiseaseClinicClinicalComputer softwareCritical CareDevelopmentDisadvantagedDiseaseDoctor of PhilosophyEducational workshopEventFosteringFunctional disorderFundingGoalsHealthHearingImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunologistImmunologyIndividualInflammationInformation DisseminationInstructionIntestinesLearningLeukocytesLife StyleLongevityMalignant NeoplasmsMedicineMetabolismMolecular MedicinePaperParticipantPatientsPersonsPublic HealthResearchResearch PersonnelRoleScientific SocietiesScientistSeminalSeriesSocietiesSumTissuesTrainingTranslationsTransplantationUnderrepresented PopulationsWomanWorkadaptive immunitycareercareer developmentcostdesigndiversity and equitydiversity and inclusionforginghuman diseaseimmune healthinnovationintimate behaviormacrophagemeetingsneuroinflammationnext generationnovel therapeutic interventionpathogenpostersprofessorprogramsresponsesingle cell analysisspecial interest groupsuccesssymposiumvirtual
项目摘要
This R13 is to support the 54th Annual Meeting of the Society for Leukocyte Biology (SLB) entitled
“Immunometabolism: Fueling the Flame of Aging, Cancer and Immunity”. SLB is the leading scientific society
with a focus on leukocytes and their roles in the pathophysiology of acute and chronic diseases. No other
scientific meeting regarding study of the immune system focuses on the leukocyte with the breadth and depth of
SLB so the annual meetings sponsored by SLB fill this void. In 2020, SLB switched to a virtual format when
meeting in person became untenable due to COVID-19. The entire planned program was executed virtually
including all scientific sessions and workshops and the intent is to do that again in 2021 using a plan informed
by the success of last year’s meeting. Funds are requested to offset administrative costs and costs of software
packages needed to host a virtual event. The goals of the annual meeting include: 1) advancement of original
and seminal research, 2) promotion of the career development of junior and new investigators, 3) dissemination
of information about the field to the wider scientific and lay audience, and 4) encouragement of the translation of
basic research in leukocyte biology to applications in the clinic. These goals will be achieved through three Aims:
Aim 1: To understand Immunometabolism as it relates to immune health and disease and to hear from
investigators working on other topics at the cutting edge of leukocyte biology. Topics will be covered by 12
Scientific Sessions entitled as follows: Immunity Across the Life Span; Tissue Resident Macrophages;
Neuroinflammation; Transplant Immunology; Intestinal Immunity; Cancer; Context Dependent Immune
Adaptation; Immunometabolism; COVID 19: Adaptive Immunity; Targeting Metabolism,Non-cancer; Single Cell
Analysis; and Western Lifestyle:Metaflammation. SLB has a commitment from a total of 40 invited speakers.
Aim 2: To provide an opportunity for new investigators and trainees to interact closely with established
scientists. An innovation for the 2021 meeting will be the SLB-SCHOOL (Society for Leukocyte Biology-
Symposium for Career development and Hands-On Opportunity to Learn) which will offer a full day instructional
workshop covering practical topics related to leukocyte research led by experts in the field. In addition, to
compensate for the absence of poster presentations that highlight in person meetings, trainees will be invited to
submit a brief powerpoint video presentation of their work which will be shown within a series of dedicated
sessions and will be followed by breakout sessions permitting in depth discussions and network opportunities.
Aim 3: To promote diversity and inclusion in the field of leukocyte biology by cultivating the participation
of women, underrepresented groups, early stage investigators and disadvantaged individuals. The Diversity,
Equity and Inclusion (DEI) committee will sponsor workshops encourage the participation of women and
scientists from underrepresented groups. In sum, the 2020 program is purposefully designed to enhance
awareness of the influence of leukocyte biology in health and disease and inspire young investigators.
本 R13 旨在支持白细胞生物学学会 (SLB) 第 54 届年会,题为
“免疫代谢:助长衰老、癌症和免疫的火焰”。 SLB 是领先的科学协会。
重点关注白细胞及其在急性和慢性疾病病理生理学中的作用。
关于免疫系统研究的科学会议重点关注白细胞,其广度和深度
SLB 因此由 SLB 赞助的年会填补了这一空白,2020 年,SLB 转向了虚拟形式。
由于新冠肺炎 (COVID-19) 的影响,面对面的会议变得无法维持,整个计划的计划都是以虚拟方式执行的。
包括所有科学会议和研讨会,目的是在 2021 年使用知情计划再次这样做
由于去年会议的成功,需要资金来抵消行政费用和软件费用。
举办虚拟活动所需的套餐包括:1)原创性的提升。
和开创性研究,2)促进初级和新研究者的职业发展,3)传播
向更广泛的科学界和非专业受众提供有关该领域的信息,以及4)鼓励翻译
从白细胞生物学的基础研究到临床应用,这些目标将通过三个目标来实现:
目标 1:了解免疫代谢与免疫健康和疾病的关系,并听取意见
12 个主题将涵盖研究白细胞生物学前沿其他主题的研究人员。
科学会议的标题如下:整个生命周期的免疫;组织驻留巨噬细胞;
神经炎症;肠道免疫;
适应;免疫代谢;COVID 19:适应性免疫;非癌症;
分析;和西方生活方式:Metaflammation 共有 40 名受邀演讲者做出承诺。
目标 2:为新研究者和受训者提供与现有研究者密切互动的机会
2021 年会议的一项创新是 SLB-SCHOOL(白细胞生物学学会)
职业发展和实践学习机会研讨会)将提供全天的教学
此外,研讨会涵盖与白细胞研究相关的实用主题。
为了弥补缺乏强调面对面会议的海报展示的不足,学员将被邀请参加
提交一份简短的 PowerPoint 视频展示其作品,该视频将在一系列专门的视频中展示
会议,随后将举行分组会议,提供深入讨论和交流机会。
目标 3:通过培养参与度来促进白细胞生物学领域的多样性和包容性
女性、代表性不足的群体、早期研究人员和弱势群体的多样性,
公平与包容 (DEI) 委员会将主办研讨会,鼓励女性参与
总之,2020 年计划的目的是增强来自代表性不足群体的科学家的能力。
认识白细胞生物学对健康和疾病的影响并激励年轻的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan S Reichner其他文献
Jonathan S Reichner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan S Reichner', 18)}}的其他基金
Investigating the Ability of Human Blood Neutrophils to Kill Cancer
研究人类血液中性粒细胞杀死癌症的能力
- 批准号:
10648774 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
55th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 55 届年会
- 批准号:
10540463 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Effect of Neutrophil Priming on Chemotaxis and Signaling
中性粒细胞启动对趋化性和信号传导的影响
- 批准号:
7847286 - 财政年份:2009
- 资助金额:
$ 1万 - 项目类别:
Effect of Neutrophil Priming on Chemotaxis and Signaling
中性粒细胞启动对趋化性和信号传导的影响
- 批准号:
6891319 - 财政年份:2003
- 资助金额:
$ 1万 - 项目类别:
Effect of Neutrophil Priming on Chemotaxis and Signaling
中性粒细胞启动对趋化性和信号传导的影响
- 批准号:
6739082 - 财政年份:2003
- 资助金额:
$ 1万 - 项目类别:
Effect of Neutrophil Priming on Chemotaxis and Signaling
中性粒细胞启动对趋化性和信号传导的影响
- 批准号:
6617060 - 财政年份:2003
- 资助金额:
$ 1万 - 项目类别:
相似国自然基金
角质形成细胞源性外泌体携载miR-31调控成纤维细胞ERK通路抗皮肤老化的作用机制
- 批准号:82373460
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
塑料光老化介导的微(纳)塑料形成和光解产物释放对雄性生殖内分泌的干扰研究
- 批准号:22376195
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
苯乙烯-丁二烯共聚物力化学老化的自由基捕获光环加成协同修复机制
- 批准号:22303065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
- 批准号:
10727092 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Role of ATII cell senescence in influenza pathogenesis in aging
ATII细胞衰老在流感发病机制中的作用
- 批准号:
10741215 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology
脓毒症病理学中的骨髓生成功能障碍和骨髓源性抑制细胞
- 批准号:
10088857 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别: